Skip to content
PubMed This is a summary of 37 peer-reviewed journal articles Updated
Medical Genetics · Koolen-de Vries Syndrome

Understanding Koolen-de Vries Syndrome (Genetics & Basics)

At a Glance

Koolen-de Vries Syndrome (KdVS) is a rare genetic condition caused by a missing or non-working KANSL1 gene on chromosome 17. It is almost always a random, 'de novo' event, meaning it was not inherited or caused by anything the parents did.

Receiving a diagnosis of Koolen-de Vries Syndrome (KdVS) can feel overwhelming, but understanding the biology behind it is a powerful first step in advocating for your child. Also known as 17q21.31 microdeletion syndrome, KdVS is a rare genetic condition that affects many systems in the body [1][2].

Importantly, children with KdVS can live long, fulfilling lives, and the condition does not typically affect life expectancy [1]. While it is a lifelong journey, knowing the “why” behind your child’s challenges—such as developmental delays, a friendly personality, or unique facial features—can help you focus on the best ways to support them [1][3].

The KANSL1 Gene: The “Master Controller”

The root cause of KdVS lies in a specific gene called KANSL1, located on chromosome 17 [4][3]. Think of this gene as an architect that helps build and maintain the “wiring” of the brain and other organs. Specifically, the KANSL1 protein helps regulate how other genes are turned on or off through a process called epigenetic regulation [5][6].

When the KANSL1 gene is not working correctly, the body cannot produce enough of this essential protein. This leads to haploinsufficiency—a medical term meaning that having only one working copy of a gene (instead of the usual two) isn’t enough for the body to function normally [1][7].

Two Ways the Diagnosis Happens

While all children with KdVS share similar traits, the genetic “typo” can happen in one of two ways:

  1. Microdeletion: A small piece of chromosome 17 (the 17q21.31 region) is missing. This missing piece includes the KANSL1 gene and often several neighboring genes [8][7].
  2. Gene Variant (Mutation): The chromosome is intact, but there is a specific “spelling error” or tiny “loss-of-function” change within the KANSL1 gene itself that stops it from working [3][5].

Both versions result in the same syndrome because the lack of a working KANSL1 gene is the main driver of the condition [1][7]. However, children with a full microdeletion may sometimes have additional health concerns, like heart defects, because those neighboring missing genes also play a role in development [3][7].

It Is Not Your Fault: The ‘De Novo’ Event

One of the most important things for parents to hear is that KdVS is almost always a de novo event [9][10]. De novo is Latin for “from the beginning.” This means the genetic change happened randomly in the egg or sperm, or very early during conception.

  • It was not caused by anything you did, ate, or were exposed to during pregnancy.
  • It is typically not inherited from either parent [9][2].
  • Because it is a random event, the risk of having another child with KdVS is usually very low (typically estimated at less than 1%) [9].

Understanding Haplotypes (H1 and H2)

In the 17q21.31 region where KdVS occurs, humans carry one of two structural patterns called haplotypes, labeled H1 and H2 [11][12]. The H2 haplotype is an “inversion,” meaning a segment of DNA is flipped backward. While carrying the H2 pattern is common and does not cause health problems on its own, research shows that the random microdeletions that cause KdVS almost always occur on a chromosome that has this H2 structure [11].

Importantly, carrying the H2 pattern is completely normal and out of anyone’s control. Passing down an H2 chromosome does not mean you caused the microdeletion [11].

How KdVS is Confirmed

Geneticists use specific tools to find these changes:

  • Chromosomal Microarray (CMA): This test looks for missing or extra pieces of DNA. It is the standard tool for finding the 17q21.31 microdeletion [9][8].
  • Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS): These tests “read” the DNA letter-by-letter. They are used to find the specific KANSL1 gene variants that a microarray might miss [13][14].

Current medical trends are shifting toward using WGS as a first-tier test because it can detect both deletions and individual gene errors at the same time [15][16].

Learn More About Managing KdVS

Common questions in this guide

What causes Koolen-de Vries Syndrome?
Koolen-de Vries Syndrome is caused by a problem with the KANSL1 gene on chromosome 17. This happens either through a small missing piece of the chromosome, called a 17q21.31 microdeletion, or a mutation within the gene itself that stops it from working properly.
Did I cause my child's KdVS diagnosis?
No, you did not cause this condition. KdVS is almost always a 'de novo' event, meaning the genetic change happened randomly during conception. It is not caused by anything you did or were exposed to during pregnancy.
What is the difference between a microdeletion and a gene variant in KdVS?
A microdeletion means a small piece of chromosome 17 is missing, taking the KANSL1 gene and sometimes neighboring genes with it. A gene variant means the chromosome is intact, but there is a spelling error in the KANSL1 gene itself that prevents it from functioning.
How do doctors test for Koolen-de Vries Syndrome?
Doctors typically use a Chromosomal Microarray to look for missing pieces of DNA, which catches the microdeletion. To find specific variants within the KANSL1 gene, they may use Whole Exome Sequencing or Whole Genome Sequencing.
What is the KANSL1 gene and what does it do?
The KANSL1 gene acts like an architect that helps build and maintain the wiring of the brain and other organs. When it does not work correctly, the body cannot produce enough of an essential protein needed for normal development.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child have a 17q21.31 microdeletion or a specific KANSL1 gene variant?
  2. 2.Was this change 'de novo,' and have we (the parents) been tested to confirm our recurrence risk?
  3. 3.Does the H1 or H2 haplotype play any role in our family's genetic profile?
  4. 4.Because of this diagnosis, what baseline screenings (such as heart or kidney ultrasounds) do you recommend?
  5. 5.Can you explain how my child's specific genetic result might influence their developmental outlook?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome.

    Moreno-Igoa M, Hernández-Charro B, Bengoa-Alonso A, et al.

    BMC medical genetics 2015; (16()):68 doi:10.1186/s12881-015-0211-0.

    PMID: 26293599
  2. 2

    Koolen-de Vries syndrome in the first adulthood patient of Southern India ancestry.

    Pascolini G, Gaudioso F, Fadda MT, et al.

    American journal of medical genetics. Part A 2021; (185(3)):978-981 doi:10.1002/ajmg.a.62006.

    PMID: 33314579
  3. 3

    Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients.

    Zollino M, Marangi G, Ponzi E, et al.

    Journal of medical genetics 2015; (52(12)):804-14 doi:10.1136/jmedgenet-2015-103184.

    PMID: 26424144
  4. 4

    The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.

    Myers KA, Mandelstam SA, Ramantani G, et al.

    Epilepsia 2017; (58(6)):1085-1094 doi:10.1111/epi.13746.

    PMID: 28440867
  5. 5

    Koolen-de Vries syndrome: A de novo missense KANSL1 variant.

    Yimenicioglu S, Kocaaga A

    Clinical neurology and neurosurgery 2022; (222()):107444 doi:10.1016/j.clineuro.2022.107444.

    PMID: 36150256
  6. 6

    A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells.

    Awamleh Z, Choufani S, Wu W, et al.

    European journal of human genetics : EJHG 2024; (32(3)):324-332 doi:10.1038/s41431-024-01538-6.

    PMID: 38282074
  7. 7

    Mouse models of 17q21.31 microdeletion and microduplication syndromes highlight the importance of Kansl1 for cognition.

    Arbogast T, Iacono G, Chevalier C, et al.

    PLoS genetics 2017; (13(7)):e1006886 doi:10.1371/journal.pgen.1006886.

    PMID: 28704368
  8. 8

    Molecular Characterization of Koolen De Vries Syndrome in Two Girls with Idiopathic Intellectual Disability from Central Brazil.

    Nascimento GR, Pinto IP, de Melo AV, et al.

    Molecular syndromology 2017; (8(3)):155-160 doi:10.1159/000456910.

    PMID: 28588437
  9. 9

    17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome.

    Bernardo P, Madia F, Santulli L, et al.

    Brain & development 2016; (38(7)):663-8.

    PMID: 26897099
  10. 10

    The clinical phenotype of Koolen-de Vries syndrome in Turkish patients and literature review.

    Karamik G, Tuysuz B, Isik E, et al.

    American journal of medical genetics. Part A 2023; (191(7)):1814-1825 doi:10.1002/ajmg.a.63207.

    PMID: 37053206
  11. 11

    Genomic architecture and functional effects of potential human inversion supergenes.

    Campoy E, Puig M, Yakymenko I, et al.

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2022; (377(1856)):20210209 doi:10.1098/rstb.2021.0209.

    PMID: 35694745
  12. 12

    Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.

    Pedicone C, Weitzman SA, Renton AE, Goate AM

    Molecular neurodegeneration 2024; (19(1)):43 doi:10.1186/s13024-024-00731-x.

    PMID: 38812061
  13. 13

    Diagnostic performance of chromosomal microarray and whole exome sequencing in fetal structural anomalies: a single-center retrospective study.

    Özer L, Aktuna S, Ünsal E

    BMC pregnancy and childbirth 2025; (25(1)):1029 doi:10.1186/s12884-025-08167-x.

    PMID: 41053595
  14. 14

    Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.

    Clark MM, Stark Z, Farnaes L, et al.

    NPJ genomic medicine 2018; (3()):16 doi:10.1038/s41525-018-0053-8.

    PMID: 30002876
  15. 15

    High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics.

    Birnbaum R, Slovik M, Zenvirt S, et al.

    Clinical genetics 2026; (109(3)):529-538 doi:10.1111/cge.70079.

    PMID: 41014177
  16. 16

    Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.

    Ko MH, Chen HJ

    Children (Basel, Switzerland) 2023; (10(3)) doi:10.3390/children10030501.

    PMID: 36980059

This page provides educational information about the genetics of Koolen-de Vries Syndrome. Always consult a genetic counselor or pediatric geneticist to interpret your child's specific genetic test results.

Get notified when new evidence is published on 17q21.31 microdeletion syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.